Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Making Use of Precision Medicine for Rheumatic Diseases
-
- Five Stories From ACR 2016
- What is the Risk of Lymphoma With Treatments?
- Keeping Cool in the Race for Precision Medicine
- The Patient With Acute Monoarticular Arthritis
- ACP Omits Treat-to-Target Approach in Latest Gout Guidelines
- ACR, EULAR Approve Classification Criteria for Sjögren’s Syndrome
- Anifrolumab Found Effective Against SLE in Phase 2b Trial
- Baricitinib Improved Patient Reported Outcomes in Phase 3 Trial
-
- Quantitative MRI Study Finds Chondroitin Sulfate Superior to Celecoxib for Knee Cartilage Loss
- Vasculitis Treatment Associated With Increased Risk for Diabetes
- Allopurinol use not linked with increased risk for chronic kidney disease
- AURA: Voclosporin Gives Hope to Patients With Lupus Nephritis
- Guselkumab Found Safe, Effective for Treatment of Psoriatic Arthritis
- PRECISION: Celecoxib Not Inferior to Ibuprofen, Naproxen in Cardiovascular Safety
- Similar Outcomes Seen With Certolizumab, MTX vs Adalimumab, MTX
- Statin use Linked With Reduced Mortality Among Patients With AS and PsA
-
- Study: Denosumab Bested Risedronate in Bone Mineral Density in Osteoporosis
- Tocilizumab plus prednisone bested prednisone alone in giant cell arteritis remission rates
- Biosimilar survey finds knowledge gaps among specialists